University of California San Francisco enrolls first patients in FDA Approved Clinical Trial to test treatment for chemotherapy-related hair loss
DigniCap® Scalp Cooling System Now Available at Leading U.S. Medical CentersNEW YORK – AUGUST 23, 2013 — Dignitana, a world leader in medical scalp-cooling technology, announced today that the University of California, San Francisco (UCSF) has only in one week´s time enrolled the first patients of the multi-center pivotal trial of the patented DigniCap® System for the prevention of chemotherapy-related hair loss. The trial, which was recently approved by the FDA, is part of the second and final phase of study in the United States and paves the way for FDA market approval of the scalp-